the progress of the strategic plan.
The plan must be monitored on a regular basis by those involved. This helps to avoid
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
et="_new"href="http://EzineArticles.com/?id=511018">dead horses and leads to the next tip.
Hold people accountable.
Moniding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
oring of the plan should create personal accountability. If your employees believe that they are part of the team striving to achieve t
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
he goals, then when others are not as dedicated they should be held accountable.
Make necessary course corrections when unknown obcts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
tacles appear.
Life is full of changes from 9/11 to fluctuating fuel prices. Course corrections need to be made when these unkno
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
n and unexpected obstacles appear.
Communicate achievement to everyone within the organization to ensure continued motivation.t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
>
Finally, communication of the plan’s status through the achievement of pre-determined goals is a great way to ensure continued
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
otivation of everyone involved. When the results are not shared, employees begin to question their work efforts. And more importantly,
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
ew" href="http://www.processspecialist.com/od.htm">strategic planning process. When your people can continually achieve shared goa
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
s that are in alignment with your strategic plan, execution becomes a daily, positive habit and is no longer a vexing continual problem
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products